Satellos Bioscience Inc. (MSLE)
Nasdaq: MSLE · Pharmaceutical Preparations · Toronto, ON · filing with the SEC since 2007
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 |
|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 |
| Report filed | Mar 27, 2026 | · |
| Research and development | 18,426 | 14,359 |
| General and administrative | 8,033 | 6,039 |
| Operating income | -26,459 | -20,398 |
| Finance income | 1,360 | 1,003 |
| Income before income taxes | -24,701 | -20,634 |
| Income tax expense | 172 | · |
| Net income | -24,873 | -20,634 |
| Earnings per share, basic | -1.70 | -2.16 |
| Earnings per share, diluted | -1.70 | -2.16 |
| Weighted average shares, basic | 14,595,771 | 9,564,862 |
| Weighted average shares, diluted | 14,595,771 | 9,564,862 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Research and development spent on inventing what it sells next
ifrs-full:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
ifrs-full:GeneralAndAdministrativeExpenseOperating income profit from running the business, before interest and tax
ifrs-full:ProfitLossFromOperatingActivitiesFinance income what its cash and investments earned
ifrs-full:FinanceIncomeIncome before income taxes profit before tax
ifrs-full:ProfitLossBeforeTaxIncome tax expense tax charged on the period's profit
ifrs-full:IncomeTaxExpenseContinuingOperationsNet income the whole group's profit, minority holders' share included
ifrs-full:ProfitLossEarnings per share, basic net income per share outstanding
ifrs-full:BasicEarningsLossPerShareEarnings per share, diluted net income per share, counting every share that could be issued
ifrs-full:DilutedEarningsLossPerShareWeighted average shares, basic the average count of shares outstanding
ifrs-full:WeightedAverageSharesWeighted average shares, diluted the average count with every share that could be issued
ifrs-full:AdjustedWeightedAverageShares